Cargando…
Dendrimer Prodrugs
The main objective of this review is to describe the importance of dendrimer prodrugs in the design of new drugs, presenting numerous applications of these nanocomposites in the pharmaceutical field. Therefore, the use of dendrimer prodrugs as carrier for drug delivery, to improve pharmacokinetic pr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274429/ https://www.ncbi.nlm.nih.gov/pubmed/27258239 http://dx.doi.org/10.3390/molecules21060686 |
_version_ | 1783377616221241344 |
---|---|
author | da Silva Santos, Soraya Igne Ferreira, Elizabeth Giarolla, Jeanine |
author_facet | da Silva Santos, Soraya Igne Ferreira, Elizabeth Giarolla, Jeanine |
author_sort | da Silva Santos, Soraya |
collection | PubMed |
description | The main objective of this review is to describe the importance of dendrimer prodrugs in the design of new drugs, presenting numerous applications of these nanocomposites in the pharmaceutical field. Therefore, the use of dendrimer prodrugs as carrier for drug delivery, to improve pharmacokinetic properties of prototype, to promote drug sustained-release, to increase selectivity and, consequently, to decrease toxicity, are just some examples of topics that have been extensively reported in the literature, especially in the last decade. The examples discussed here give a panel of the growing interest dendrimer prodrugs have been evoking in the scientific community. |
format | Online Article Text |
id | pubmed-6274429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62744292018-12-28 Dendrimer Prodrugs da Silva Santos, Soraya Igne Ferreira, Elizabeth Giarolla, Jeanine Molecules Review The main objective of this review is to describe the importance of dendrimer prodrugs in the design of new drugs, presenting numerous applications of these nanocomposites in the pharmaceutical field. Therefore, the use of dendrimer prodrugs as carrier for drug delivery, to improve pharmacokinetic properties of prototype, to promote drug sustained-release, to increase selectivity and, consequently, to decrease toxicity, are just some examples of topics that have been extensively reported in the literature, especially in the last decade. The examples discussed here give a panel of the growing interest dendrimer prodrugs have been evoking in the scientific community. MDPI 2016-05-31 /pmc/articles/PMC6274429/ /pubmed/27258239 http://dx.doi.org/10.3390/molecules21060686 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review da Silva Santos, Soraya Igne Ferreira, Elizabeth Giarolla, Jeanine Dendrimer Prodrugs |
title | Dendrimer Prodrugs |
title_full | Dendrimer Prodrugs |
title_fullStr | Dendrimer Prodrugs |
title_full_unstemmed | Dendrimer Prodrugs |
title_short | Dendrimer Prodrugs |
title_sort | dendrimer prodrugs |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274429/ https://www.ncbi.nlm.nih.gov/pubmed/27258239 http://dx.doi.org/10.3390/molecules21060686 |
work_keys_str_mv | AT dasilvasantossoraya dendrimerprodrugs AT igneferreiraelizabeth dendrimerprodrugs AT giarollajeanine dendrimerprodrugs |